Focus Taiwan App
Download

Mistaken disclosure of remdesivir failure surprises Taiwan: CECC

04/24/2020 10:22 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, April 24 (CNA) The mistaken publication by the World Health Organization (WHO) of results of a clinical trial on remdesivir, a potential therapy for COVID-19 patients, surprised Taiwan, but will not affect the separate trial in which it is participating.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.46